The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(4-((3-(4-(3-(4-methylpiperazin-1-yl)propoxy)phenyl)-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)phenoxy)phenyl)acetamide ID: ALA3763983
Chembl Id: CHEMBL3763983
PubChem CID: 127040247
Max Phase: Preclinical
Molecular Formula: C32H34N4O4S2
Molecular Weight: 602.78
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)Nc1ccc(Oc2ccc(/C=C3\SC(=S)N(c4ccc(OCCCN5CCN(C)CC5)cc4)C3=O)cc2)cc1
Standard InChI: InChI=1S/C32H34N4O4S2/c1-23(37)33-25-6-12-29(13-7-25)40-28-10-4-24(5-11-28)22-30-31(38)36(32(41)42-30)26-8-14-27(15-9-26)39-21-3-16-35-19-17-34(2)18-20-35/h4-15,22H,3,16-21H2,1-2H3,(H,33,37)/b30-22-
Standard InChI Key: SFPDRNYPUILMPY-SWKFRHMKSA-N
Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 602.78Molecular Weight (Monoisotopic): 602.2021AlogP: 5.86#Rotatable Bonds: 10Polar Surface Area: 74.35Molecular Species: NEUTRALHBA: 8HBD: 1#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2CX Acidic pKa: CX Basic pKa: 8.11CX LogP: 5.13CX LogD: 4.34Aromatic Rings: 3Heavy Atoms: 42QED Weighted: 0.18Np Likeness Score: -1.58
References 1. Kim D, Kim YG, Seo JH, Shin KJ.. (2016) Identification and characterization of potent, selective and metabolically stable IKKβ inhibitor., 26 (4): [PMID:26826731 ] [10.1016/j.bmcl.2016.01.065 ]